KP Tissue Inc (KPT) - Total Assets
Based on the latest financial reports, KP Tissue Inc (KPT) holds total assets worth CA$71.60 Million CAD (≈ $51.80 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check KP Tissue Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
KP Tissue Inc - Total Assets Trend (2012–2025)
This chart illustrates how KP Tissue Inc's total assets have evolved over time, based on quarterly financial data. Explore KPT long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
KP Tissue Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
KP Tissue Inc's total assets of CA$71.60 Million consist of 2.5% current assets and 97.5% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 0.0% |
| Accounts Receivable | CA$1.80 Million | 2.5% |
| Inventory | CA$0.00 | 0.0% |
| Property, Plant & Equipment | CA$0.00 | 0.0% |
| Intangible Assets | CA$0.00 | 0.0% |
| Goodwill | CA$0.00 | 0.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how KP Tissue Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is KP Tissue Inc worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: KP Tissue Inc's current assets represent 2.5% of total assets in 2025, an increase from 0.0% in 2012.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2025, the same as 0.0% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
- Asset Diversification: The largest asset category is accounts receivable at 2.5% of total assets.
KP Tissue Inc Competitors by Total Assets
Key competitors of KP Tissue Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Natura &Co Holding S.A.
SA:NTCO3
|
Brazil | R$34.86 Billion |
|
Silicon2 Co. Ltd.
KQ:257720
|
Korea | ₩668.12 Billion |
|
Lafang China
SHG:603630
|
China | CN¥2.18 Billion |
|
Perfect Group Corp Ltd Class A
SHG:603059
|
China | CN¥2.35 Billion |
|
FCW Holdings Bhd
KLSE:2755
|
Malaysia | RM400.60 Million |
|
Rigolleau SA
BA:RIGO
|
Argentina | AR$154.64 Billion |
|
ZOONO Group Ltd
AU:ZNO
|
Australia | AU$6.01 Million |
|
Skin Elements Ltd
AU:SKN
|
Australia | AU$2.01 Million |
KP Tissue Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.00 | 1.00 | 0.74 |
| Quick Ratio | 1.00 | 1.00 | 0.74 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CA$0.00 | CA$0.00 | CA$-617.00K |
KP Tissue Inc - Advanced Valuation Insights
This section examines the relationship between KP Tissue Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.56 |
| Latest Market Cap to Assets Ratio | 1.34 |
| Asset Growth Rate (YoY) | 0.4% |
| Total Assets | CA$71.60 Million |
| Market Capitalization | $96.14 Million USD |
Valuation Analysis
Above Book Valuation: The market values KP Tissue Inc's assets above their book value (1.34x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: KP Tissue Inc's assets grew by 0.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for KP Tissue Inc (2012–2025)
The table below shows the annual total assets of KP Tissue Inc from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CA$71.60 Million ≈ $51.80 Million |
+0.40% |
| 2024-12-31 | CA$71.31 Million ≈ $51.59 Million |
+1.00% |
| 2023-12-31 | CA$70.61 Million ≈ $51.08 Million |
-13.59% |
| 2022-12-31 | CA$81.71 Million ≈ $59.11 Million |
+1.23% |
| 2021-12-31 | CA$80.72 Million ≈ $58.39 Million |
+13.19% |
| 2020-12-31 | CA$71.31 Million ≈ $51.59 Million |
-14.11% |
| 2019-12-31 | CA$83.03 Million ≈ $60.06 Million |
-21.17% |
| 2018-12-31 | CA$105.34 Million ≈ $76.20 Million |
+4.13% |
| 2017-12-31 | CA$101.16 Million ≈ $73.18 Million |
-15.29% |
| 2016-12-31 | CA$119.41 Million ≈ $86.38 Million |
-7.49% |
| 2015-12-31 | CA$129.08 Million ≈ $93.38 Million |
-16.90% |
| 2014-12-31 | CA$155.33 Million ≈ $112.37 Million |
-4.80% |
| 2013-12-31 | CA$163.17 Million ≈ $118.03 Million |
+15.91% |
| 2012-12-31 | CA$140.77 Million ≈ $101.83 Million |
-- |
About KP Tissue Inc
KP Tissue Inc., through its interest in Kruger Products Inc., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through the Consumer and Away-From-Home segments. It offers bathroom and facial tissues, paper towels, and napkins. The company markets its products under Cashmere, Purex, Scotties, SpongeTowels, Bonterr… Read more